.png)
Meet the brand turning cognitive health, focus, and mental recovery into a measurable daily signal.
Neurable has raised $35 million in Series A funding to accelerate the commercialization of its noninvasive brain-computer interface (BCI) technology—pushing cognitive health, focus, and mental recovery out of research labs and into daily consumer use.
The round was led by Spectrum Moonshot Fund, bringing Neurable’s total capital raised to $65 million, and signals growing investor confidence that brain data is becoming the next foundational layer of health and performance technology.
Neurable is scaling its patented Neurable AI platform, a compact brain-signal processing system designed to integrate seamlessly into everyday devices. Unlike traditional BCI systems that require clinical setups or invasive hardware, Neurable’s technology enables real-time brain-state detection in consumer-grade products.
The company recently introduced the MW75 Neuro LT, alongside a redesigned Neurable app that provides live insight into:
These capabilities have been validated across multiple independent evaluations and peer-reviewed studies, demonstrating high-fidelity detection of cognitive state changes such as focus, distraction, and mental load.
“Our mission is to make understanding your brain as natural as checking your steps,” said Dr. Ramses Alcaide, CEO and Co-Founder of Neurable. “This funding allows us to scale cognitive insight into the devices people already use every day.”
Investor interest reflects a broader shift toward brain-centric wellness and performance tools—as cognitive endurance, attention, and mental recovery become limiting factors in work, sport, and everyday life.
“We invested in Neurable because they’ve achieved something rare: bringing high-quality BCI into an elegant consumer product,” said Mauro Guebeli, Investment Manager at Spectrum Value Management.
Existing backers echoed the sentiment, emphasizing Neurable’s ability to translate deep science into usable products.
“We view Neurable as a leader in making brain health accessible, effective, and desirable,” said Marius Swart, Managing Partner at Pace Ventures.
With new funding, Neurable plans to expand its platform across multiple sectors where cognitive performance directly impacts outcomes, including:
“Gaming is one of the most intuitive applications of Neurable AI,” said Adam Molnar, Co-Founder and VP of Strategic Partnerships. “Small gains in concentration and cognitive endurance can change competitive outcomes.”
The global brain-computer interface market is projected to exceed $52 billion by 2034, as demand grows for technologies that go beyond tracking physical outputs to understanding mental inputs.
Neurable’s approach positions cognitive health alongside sleep, recovery, and cardiovascular metrics—turning the brain into a measurable, trainable system rather than a black box.
Neurable isn’t building a futuristic science experiment—it’s building brain infrastructure.
As performance culture expands beyond the body, expect cognitive metrics like focus, fatigue, and mental recovery to become as standard as heart rate variability. Neurable’s $35M raise signals that the next frontier of health, sport, and productivity will be decided as much in the mind as in the muscles.
The brain is becoming the next wearable.
.png)
.png)
